Parkinson’s Disease Medication Use

Project Title Parkinson’s Disease Medication Use
Date Posted
Friday, June 7, 2013
Project ID

Modular program-based one-time assessment of the use of three different drugs for Parkinson’s Disease, carbidopa/levodopa, entacapone, and combination product carbidopa, levodopa, and entacapone (Stalevo), in the Mini-Sentinel Distributed Database. Two categories of counts were generated: (1) incident counts with respect to each of the medications, and (2) prevalent counts (i.e., counts of users with at least one dispensing during the period of interest [January 2000- December 2010]). Modular programs are adaptable standardized programs. Results were generated using Modular Program 1; click here for more information. Programs were executed in February 2011.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
combination product of carbidopa
levodopa and entacapone (Stalevo)
Population / Cohort
All individuals
Time Period
January 1, 2000 - December 31, 2010
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
Scroll to Top